J.P. Morgan Private Wealth Advisors’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-7,267
| Closed | -$444K | – | 1788 |
|
2020
Q4 | $444K | Buy |
7,267
+41
| +0.6% | +$2.51K | ﹤0.01% | 1332 |
|
2020
Q3 | $338K | Hold |
7,226
| – | – | ﹤0.01% | 1309 |
|
2020
Q2 | $367K | Hold |
7,226
| – | – | ﹤0.01% | 1227 |
|
2020
Q1 | $322K | Buy |
7,226
+210
| +3% | +$9.36K | ﹤0.01% | 1103 |
|
2019
Q4 | $337K | Hold |
7,016
| – | – | ﹤0.01% | 1187 |
|
2019
Q3 | $237K | Hold |
7,016
| – | – | ﹤0.01% | 1280 |
|
2019
Q2 | $316K | Sell |
7,016
-2,818
| -29% | -$127K | ﹤0.01% | 1129 |
|
2019
Q1 | $370K | Buy |
9,834
+276
| +3% | +$10.4K | ﹤0.01% | 1129 |
|
2018
Q4 | $328K | Buy |
9,558
+380
| +4% | +$13K | ﹤0.01% | 1125 |
|
2018
Q3 | $431K | Buy |
9,178
+2,118
| +30% | +$99.5K | ﹤0.01% | 1127 |
|
2018
Q2 | $238K | Buy |
+7,060
| New | +$238K | ﹤0.01% | 1294 |
|
2017
Q2 | – | Sell |
-15,783
| Closed | -$155K | – | 1333 |
|
2017
Q1 | $155K | Sell |
15,783
-218
| -1% | -$2.14K | ﹤0.01% | 1270 |
|
2016
Q4 | $175K | Buy |
16,001
+3,184
| +25% | +$34.8K | ﹤0.01% | 1178 |
|
2016
Q3 | $180K | Sell |
12,817
-23
| -0.2% | -$323 | ﹤0.01% | 1157 |
|
2016
Q2 | $90K | Buy |
+12,840
| New | +$90K | ﹤0.01% | 1211 |
|